Eam Global Investors LLC Assembly Biosciences, Inc. Transaction History

Eam Global Investors LLC

  • $402 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 03, 2018
SELL
$39.21 - $50.29 $938,726 - $1.2 Million
-23,941 Closed
0 $0
Q1 2018

Jun 04, 2018
SELL
$41.7 - $64.16 $128,894 - $198,318
-3,091 Reduced 11.43%
23,941 $1.18 Million
Q4 2017

Jun 04, 2018
BUY
$28.58 - $49.91 $772,574 - $1.35 Million
27,032
27,032 $1.22 Million

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0
View Full List

About ASSEMBLY BIOSCIENCES, INC.

ASMB Quotes by TradingView
  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $822M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email